Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis

BACKGROUND: Thermal ablation (TA) is considered a safe alternative to surgical resection for the treatment of non-small cell lung cancer (NSCLC). While previous studies have shown that TA is beneficial for stage I NSCLC patients, however, few have reported on TA efficacy in patients with stage II-II...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wei-Yu, He, Yu, Hu, Qikang, Peng, Muyun, Zhang, Zhe, Xie, Shouzhi, Yu, Fenglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446892/
https://www.ncbi.nlm.nih.gov/pubmed/36081544
http://dx.doi.org/10.3389/fonc.2022.984932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446892/
https://www.ncbi.nlm.nih.gov/pubmed/36081544
http://dx.doi.org/10.3389/fonc.2022.984932

Ejemplares similares